Researchers from Penn State College of Engineering are aiming to speed COVID-19 drug discovery with quantum machine learning, a field that combines machine learning and quantum physics.
For more...
As COVID-19 has made its way across the US and around the world, healthcare stakeholders from all areas of the industry have prioritized containing the outbreak. Leaders at all levels have utilized...
A team from Northwestern University has developed an artificial intelligence platform that can quickly identify research that has the most potential to produce COVID-19 treatments and solutions.
For...
Partners HealthCare, Biogen Inc., and Broad Institute of MIT and Harvard are partnering to launch a big data biobank for coronavirus research.
For more coronavirus updates, visit our resource...
In the months since COVID-19 has evolved from a blip on the world’s radar to a full-blown global health crisis, the virus has managed to shine a glaring light on some of healthcare’s most foundational cracks.
Gaps in...
The Harvard T.H. Chan School of Public Health and the Human Vaccines Project have announced the Human Immunomics Initiative, a joint effort that will use artificial intelligence models to accelerate...
A team from the University of Texas Medical Branch at Galveston (UTMB) has developed a reverse genetic system for coronavirus that could help researchers evaluate and discover potential vaccines,...
Machine learning algorithms have the potential to accelerate and refine the drug development process, but the industry should expand data access and create consistent data standards to ensure drug...
